Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 122 |
---|---|
Genomic Coordinate (GRCh38) | g.22076388_22077702del |
Variant | c.350-?_663+?del |
Variant Start Position | 350 |
Location | Exons 4-5 |
Amino Acid Change | Deletion (Exons 4-5) |
ACMG Call | Pathogenic |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Likely Pathogenic | Effect Type | Deletion |
Variant Type | CNV |
PMID | 16636593, 9199930, 34806794 |
Article Count | 3 |
Times Observed | 3-5 |
Clinical Phenotype | - |
ACMG Categories | - |
ACMG Explanations | - |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | - |
No Contrary Evidence Found | No |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | - |
GnomAD Alleles | - |
DBNSFP Alleles | - |
Other Alleles | - |
Note | nan |
Warnings | - |